ESC 365 - Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

HFA Premium Access

Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Session: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Topic: Nonpharmacological Treatment

Speaker: Professor M. Kleiner Shochat (Hadera, IL)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)

3 presentations

1 follower

14 more presentations in this session

STADE-HF: A Titration based on sST2 is safe but failed to decrease readmissions in patients admitted for acute heart failure.

Speaker: Mr J. Nicoleau (Montpellier, FR)

Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre

Speaker: Miss S. Lyu (Beijing, CN)

Interplay of stress regulatory transcription factors in human cardiac valvular disorders leading to heart failure and cross talk of NFAtc3 nuclear localization invitro.

Speaker: Professor I. Murtaza (Islamabad, PK)

Who is taking care of decompensations of patients after a de novo AHF episode? An outlook on the natural history through the NOVICA cohort

Speaker: Doctor O. Miro (Barcelona, ES)

Analysis on how the emergency physician decision of hospitalization or discharge home patients with acute heart failure matches with the risk categories stratified by the MEESSI scale

Speaker: Doctor O. Miro (Barcelona, ES)

Access the full session

Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Speakers: Professor M. Kleiner Shochat, Mr J. Nicoleau, Miss S. Lyu, Professor I. Murtaza, Doctor O. Miro...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources